and Human Services (HHS)
AMENDMENT TO RFA-HL-02-028: HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) CARDIOVASCULAR TOXICITIES RELEASE DATE: October 31, 2002 NOTICE: NOT-HL-03-002 National Heart, Lung, and Blood Institute (NHLBI) (http://www.nhlbi.nih.gov) National Institute of Child Health and Human Development (NICHD) (http://www.nichd.nih.gov) The purpose of this Notice is to change the NHLBI contacts for RFA HL-02-028 that was published in the NIH Guide on March 7, 2002: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-02-028.html All other aspects of the RFA remain unchanged. o Direct your questions about scientific/research issues to: Suzanne Goldberg, R.N., M.S.N. Division of Heart and Vascular Diseases National Heart, Lung, and Blood Institute Rockledge II, Room 9174 MSC 7940 6701 Rockledge Drive Bethesda, MD 20892-7940 Phone: 301-435-0515 FAX: 301-480-1336 Email: [email protected] Lynne M. Mofenson, M.D. Pediatric, Adolescent and Maternal AIDS Branch Center for Research for Mothers and Children National Institute of Child Health and Human Development National Institutes of Health 6100 Executive Boulevard, Room 4B11 Rockville, MD 20852 Telephone: 301-435-6870 Fax: 301-496-8678 Email: [email protected] o Direct your questions about peer review issues to: Anne Clark, Ph.D. Chief, Review Branch Division of Extramural Affairs National Heart, Lung, and Blood Institute 6701 Rockledge Dr., Room 7178 (MSC 7924) Bethesda, MD 20892-7924 (20817 for Courier) Telephone: (301) 435-0270 FAX: (301) 480-0730 Email: [email protected] o Direct your questions about financial or grants management matters to: Ms. Carol Lander Grants Operations Branch National Heart, Lung, and Blood Institute 6701 Rockledge Drive Suite 7159, MSC 7926 Bethesda, MD 20892-7926 Telephone: (301) 435-0150 FAX: (301) 480-3310 Email: [email protected]
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
| ||||||
|
|
|
Department of Health and Human Services (HHS) |
|
|||
|
NIH... Turning Discovery Into Health® |
||||||